TRC105
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for TRC105, covering 2012-03-05 to 2023-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer [Phase 1, Phase 2]